Vitamin D, Vitamin D binding protein, and cardiovascular disease

Vitamin-Binding Proteins: Functional Consequences

Volumn , Issue , 2013, Pages 107-126

  Berry, Diane ^a   Hyppönen, Elina ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054742384     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15313     Document Type: Chapter

References (138)

1. Ahn, J., Yu, K., Stolzenberg-Solomon, R., et al. 2010. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet, 19: 2739-45.
2. Aihara, K., Azuma, H., Akaike, M., et al. 2004. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem, 279: 35798-802.
3. Arnaud, J., & Constans, J. 1993. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet, 92: 183-8.
4. Arora, P., Garcia-Bailo, B., Dastani, Z., et al. 2011. Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes. BMC Med Genet, 12: 95.
5. Bae, S., Yalamarti, B., Ke, Q., et al. 2011. Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc Res, 91: 632-9.
6. Berry, D., & Hyppönen, E. 2011. Determinants of vitamin D status: Focus on genetic variations. Curr Opin Nephrol Hypertens, 20: 331-6.
7. Berry, D. J. 2012. Analysing the association of vitamin D status on selected cardiovascular risk markers using seasonal and genetic variations. PhD thesis, University College London.
8. Bikle, D. D., Gee, E., Halloran, B., et al. 1986a. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab, 63: 954-9.
9. Bikle, D. D., Halloran, B. P., Gee, E., Ryzen, E., & Haddad, J. G. 1986b. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest, 78: 748-52.
10. Bischoff-Ferrari, H. A. 2012. Relevance of vitamin D in muscle health. Rev Endocr Metab Disord, 13: 71-7.
11. Bjelakovic, G., Gluud, L. L., Nikolova, D., et al. 2011. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev: CD007470.
12. Bland, R., Markovic, D., Hills, C. E., et al. 2004. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol, 89-90: 121-5.
13. Bogaerts, I., Vergoven, C., Van Baelen, H., & Bouillon, R. 2005. New aspects of DBP. In: Feldman, D., Glorieux, F. H., & Pike, J. W. (eds.). Vitamin D. Amsterdam: Elsevier Academic Press.
14. Bolland, M. J., Grey, A. B., Ames, R. W., et al. 2007. Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf), 67: 259-64.
15. Bouillon, R., Van Baelen, H., & De Moor, P. 1980. Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem, 13: 1029-34.
16. Braun, A., Bichlmaier, R., & Cleve, H. 1992. Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): Allelic differences of the common genetic GC types. Hum Genet, 89: 401-6.
17. Briese, S., Wiesner, S., Will, J. C., et al. 2006. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant, 21: 1906-14.
18. Burgaz, A., Orsini, N., Larsson, S. C., & Wolk, A. 2011. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens, 29: 636-45.
19. Carter, K. W., Mccaskie, P. A., & Palmer, L. J. 2008. SimHap GUI: An intuitive graphical user interface for genetic association analysis. BMC Bioinformatics, 9: 557.
20. Cheema, C., Grant, B. F., & Marcus, R. 1989. Effects of estrogen on circulating “free” and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women. J Clin Invest, 83: 537-42.
21. Chen, S., Glenn, D. J., Ni, W., et al. 2008. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension, 52: 1106-12.
22. Chen, Y., Kong, J., Sun, T., et al. 2011. 1,25-Dihydroxyvitamin D suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-kappaB activation. Arch Biochem Biophys, 507: 241-7.
23. Cheng, Q., Li, Y. C., Boucher, B. J., & Leung, P. S. 2011. A novel role for vitamin D: Modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia, 54: 2077-81.
24. Cheng, S., Massaro, J. M., Fox, C. S., et al. 2010. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes, 59: 242-248.
25. Choi, J. H., Ke, Q., Bae, S., et al. 2011. Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats. J Card Fail, 17: 1051-8.
26. Chun, R. F., Peercy, B. E., Adams, J. S., & Hewison, M. 2012. Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: Analysis by mathematical modeling. PLoS One, 7: e30773.
27. Cleve, H., & Bearn, A. G. 1961. Inherited variations in human serum proteins: Studies on the group-specific component. Ann N Y Acad Sci, 94: 218-24.
28. Constans, J., & Viau, M. 1977. Group-specific component: Evidence for two subtypes of the Gc1 gene. Science, 198: 1070-1.
29. Cooke, N. E., & David, E. V. 1985. Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest, 76: 2420-4.
30. Daiger, S. P., Schanfield, M. S., & Cavalli-Sforza, L. L. 1975. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci U S A, 72: 2076-80.
31. Davey Smith, G., & Ebrahim, S. 2003. “Mendelian randomization”: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol, 32: 1-22.
32. Deluca, H. F. 2008. Evolution of our understanding of vitamin D. Nutr Rev, 66: S73-S87.
33. Detrano, R., Guerci, A. D., Carr, J. J., et al. 2008. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med, 358: 1336-45.
34. Dorjgochoo, T., Shi, J., Gao, Y. T., et al. 2011. Genetic variants in vitamin D metabolism-related genes and body mass index: Analysis of genome-wide scan data of approximately 7000 Chinese women. Int J Obes (Lond), 36(9): 1252-5.
35. Drincic, A. T., Armas, L. A., Van Diest, E. E., & Heaney, R. P. 2012. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring), 20(7): 1444-8.
36. Dueland, S., Blomhoff, R., & Pedersen, J. I. 1990. Uptake and degradation of vitamin D binding protein and vitamin D binding protein-actin complex in vivo in the rat. Biochem J, 267: 721-5.
37. Earthman, C. P., Beckman, L. M., Masodkar, K., & Sibley, S. D. 2012. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: Considerations and implications. Int J Obes (Lond), 36(3): 387-96.
38. Elamin, M. B., Abu Elnour, N. O., Elamin, K. B., et al. 2011. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. J Clin Endocrinol Metab, 96: 1931-42.
39. Equils, O., Naiki, Y., Shapiro, A. M., et al. 2006. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol, 143: 58-64.
40. Fang, Y., Van Meurs, J. B., Arp, P., et al. 2009. Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int, 85: 85-93.
41. Forouhi, N. G., Ye, Z., Rickard, A. P., et al. 2012. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: Results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia, 55(8): 2173-82.
42. Forrest, K. Y., & Stuhldreher, W. L. 2011. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res, 31: 48-54.
43. Goldsmith, D. J., Covic, A., Sambrook, P. A., & Ackrill, P. 1997. Vascular calcification in long-term haemodialysis patients in a single unit: A retrospective analysis. Nephron, 77: 37-43.
44. Gressner, O. A., Gao, C., Siluschek, M., Kim, P., & Gressner, A. M. 2009. Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 21: 990-5.
45. Haddad, J. G., Jr., & Hahn, T. J. 1973. Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature, 244: 515-7.
46. Heid, I. M., Jackson, A. U., Randall, J. C., et al. 2010. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet, 42: 949-60.
47. Hirai, M., Suzuki, S., Hinokio, Y., et al. 1998. Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia, 41: 742-3.
48. Hirai, M., Suzuki, S., Hinokio, Y., et al. 2000. Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. J Clin Endocrinol Metab, 85: 1951-3.
49. Hiroki, T., Song, Y. H., Liebhaber, S. A., & Cooke, N. E. 2006. The human vitamin D-binding protein gene contains locus control determinants sufficient for autonomous activation in hepatic chromatin. Nucleic Acids Res, 34: 2154-65.
50. Hirschfeld, J. 1959. Immune-electrophoretic demonstration of qualitative differences in human sera and their relation to the haptoglobins. Acta Pathol Microbiol Scand, 47: 160-8.
51. Hirschfeld, J., Jonsson, B., & Rasmuson, M. 1960. Inheritance of a new group-specific system demonstrated in normal human sera by means of an immuno-electrophoretic technique. Nature, 185: 931-2.
52. Holick, M. F. 1995. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr, 61: 638S-645S.
53. Holick, M. F., Maclaughlin, J. A., & Doppelt, S. H. 1981. Regulation of cutaneous previtamin D3 photosynthesis in man: Skin pigment is not an essential regulator. Science, 211: 590-3.
54. Hollis, B. W. 1984. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem, 21: 81-6.
55. Horst, R., Reinhardt, T., & Satyanarayana Reddy, G. 2005. Vitamin D metabolism. In: Feldman, D., Glorieux, F. H., & Pike, J. W. (eds.) Vitamin D. 2nd ed. Amsterdam: Elsevier Academic Press.
56. Hunter, D., De Lange, M., Snieder, H., et al. 2001. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res, 16: 371-8.
57. Hyppönen, E., Berry, D. J., Wjst, M., & Power, C. 2009. Serum 25-hydroxyvitamin D and IgE-a significant but nonlinear relationship. Allergy, 64: 613-20.
58. Hyppönen, E., & Power, C. 2007. Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr, 85: 860-8.
59. Institute of Medicine. 2011. Dietary reference intakes for calcium and vitamin D. Ross, A. C., Taylor, C. L., Yaktine, A. L., & Del Valle, H. B. (eds.). Washington, DC.
60. Jackson, R. D., Lacroix, A. Z., Gass, M., et al. 2006. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med, 354: 669-83.
61. Janmey, P. A., Lamb, J. A., Ezzell, R. M., Hvidt, S., & Lind, S. E. 1992. Effects of actin filaments on fibrin clot structure and lysis. Blood, 80: 928-36.
62. Jiang, H., Xiong, D. H., Guo, Y. F., et al. 2007. Association analysis of vitamin D-binding protein gene polymorphisms with variations of obesity-related traits in Caucasian nuclear families. Int J Obes (Lond), 31: 1319-24.
63. Jones, G. 2008a. Vitamin D. In: Kiple, K. F., & Conee Ornelas, K. (eds.) The Cambridge world history of food (pp. 763-768). Cambridge, UK: Cambridge University Press.
64. Jones, G. 2008b. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr, 88: 582S-586S.
65. Jorde, R., & Grimnes, G. 2011. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res, 50: 303-12.
66. Jorde, R., Sneve, M., Emaus, N., Figenschau, Y., & Grimnes, G. 2010. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: The Tromso study. Eur J Nutr, 49: 401-7.
67. Jorgensen, C. S., Christiansen, M., Norgaard-Pedersen, B., et al. 2004. Gc globulin (vitamin D-binding protein) levels: An inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serum. Scand J Clin Lab Invest, 64: 157-66.
68. Kawakami, M., Blum, C. B., Ramakrishnan, R., Dell, R. B., & Goodman, D. S. 1981. Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjects. J Clin Endocrinol Metab, 53: 1110-6.
69. Kawakami, M., Imawari, M., & Goodman, D. S. 1979. Quantitative studies of the interaction of cholecalciferol (vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols. Biochem J, 179: 413-23.
70. Kew, R. R., & Webster, R. O. 1988. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest, 82: 364-9.
71. Klupa, T., Malecki, M., Hanna, L., et al. 1999. Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. Eur J Endocrinol, 141: 490-3.
72. Laing, C. J., & Cooke, N. K. 2005. Vitamin D binding protein. In: Feldman, D., Glorieux, F. H., & Pike, J. W. (eds.) Vitamin D (pp.117-134). Amsterdam: Elsevier Academic Press.
73. Lamberg-Allardt, C. 2006. Vitamin D in foods and as supplements. Prog Biophys Mol Biol, 92: 33-8.
74. Lauridsen, A. L., Vestergaard, P., Hermann, A. P., et al. 2005. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): A cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int, 77: 15-22.
75. Lauridsen, A. L., Vestergaard, P., & Nexo, E. 2001. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem, 47: 753-6.
76. Li, Y. C. 2012. Vitamin D: roles in renal and cardiovascular protection. Curr Opin Nephrol Hypertens, 21: 72-9.
77. Li, Y. C., Kong, J., Wei, M., et al. 2002. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest, 110: 229-38.
78. Maestro, B., Davila, N., Carranza, M. C., & Calle, C. 2003. Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol, 84: 223-30.
79. Maestro, B., Molero, S., Bajo, S., Davila, N., & Calle, C. 2002. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct, 20: 227-32.
80. Malecki, M. T., Klupa, T., Wanic, K., et al. 2002. Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes Res Clin Pract, 57: 99-104.
81. Manson, J. E., Allison, M. A., Carr, J. J., et al. 2010. Calcium/vitamin D supplementation and coronary artery calcification in the Women’s Health Initiative. Menopause, 17: 683-91.
82. Martins, D., Wolf, M., Pan, D., et al. 2007. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med, 167: 1159-65.
83. McLeod, J. F., & Cooke, N. E. 1989. The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: Detection of transcripts in multiple tissues. J Biol Chem, 264: 21760-9.
84. Mitri, J., Muraru, M. D., & Pittas, A. G. 2011. Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr, 65: 1005-15.
85. Mitsuhashi, T., Morris, R. C., Jr., & Ives, H. E. 1991. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest, 87: 1889-95.
86. Nishio, H., & Dugaiczyk, A. 1996. Complete structure of the human alpha-albumin gene, a new member of the serum albumin multigene family. Proc Natl Acad Sci U S A, 93: 7557-61.
87. Nykjaer, A., Dragun, D., Walther, D., et al. 1999. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell, 96: 507-15.
88. Nykjaer, A., Fyfe, J. C., Kozyraki, R., et al. 2001. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci U S A, 98: 13895-900.
89. O’Connell, T. D., & Simpson, R. U. 1996. Immunochemical identification of the 1,25-dihydroxyvitamin D3 receptor protein in human heart. Cell Biol Int, 20: 621-4.
90. Oh, J., Weng, S., Felton, S. K., et al. 2009. 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation, 120: 687-98.
91. Ohsawa, M., Koyama, T., Yamamoto, K., et al. 2000. 1Alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation, 102: 2867-72.
92. Penna, G., & Adorini, L. 2000. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol, 164: 2405-11.
93. Pike, J. W., Gooze, L. L., & Haussler, M. R. 1980. Biochemical evidence for 1,25-dihydroxyvitamin D receptor macromolecules in parathyroid, pancreatic, pituitary, and placental tissues. Life Sci, 26: 407-14.
94. Pike, J. W., & Shevde, N. K. 2005. The vitamin D receptor. In: Feldman, D., Glorieux, F. H., & Pike, J. W. (eds.) Vitamin D (pp.167-192). Amsterdam: Elsevier Academic Press.
95. Pittas, A. G., Chung, M., Trikalinos, T., et al. 2010. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med, 152: 307-14.
96. Powe, C. E., Ricciardi, C., Berg, A. H., et al. 2011. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res, 26: 1609-16.
97. Ramagopalan, S. V., Heger, A., Berlanga, A. J., et al. 2010. A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Res, 20: 1352-60.
98. Raymond, M. A., Desormeaux, A., Labelle, A., et al. 2005. Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor. Biochem Biophys Res Commun, 338: 1374-82.
99. Reid, D., Toole, B. J., Knox, S., et al. 2011. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr, 93: 1006-11.
100. Rocha, V. Z., & Libby, P. 2009. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol, 6: 399-409.
101. Rodriguez, M., Martinez-Moreno, J. M., Rodriguez-Ortiz, M. E., Munoz-Castaneda, J. R., & Almaden, Y. 2011. Vitamin D and vascular calcification in chronic kidney disease. Kidney Blood Press Res, 34: 261-8.
102. Saadi, H. F., Nagelkerke, N., Benedict, S., et al. 2006. Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women. Bone, 39: 113-43.
103. Scarborough, P., Bhatnagar, P., Wickramasinghe, K., et al. 2010. Mortality (Online). London: British Heart Foundation.
104. Schuster, I. 2011. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta, 1814: 186-99.
105. Selby, P. L., Davies, M., Marks, J. S., & Mawer, E. B. 1995. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol (Oxf), 43: 531-6.
106. Shea, M. K., Benjamin, E. J., Dupuis, J., et al. 2009. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr, 63: 458-464.
107. Shen, H., Bielak, L. F., Ferguson, J. F., et al. 2010. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol, 30: 2648-54.
108. Shephard, R. M., & Deluca, H. F. 1980. Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes. Arch Biochem Biophys, 202: 43-53.
109. Shroff, R., Egerton, M., Bridel, M., et al. 2008. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol, 19: 1239-46.
110. Shultz, T. D., Fox, J., Heath, H., III, & Kumar, R. 1983. Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination. Proc Natl Acad Sci U S A 80: 1746-50.
111. Sokol, S. I., Tsang, P., Aggarwal, V., Melamed, M. L., & Srinivas, V. S. 2011. Vitamin D status and risk of cardiovascular events: Lessons learned via systematic review and meta-analysis. Cardiol Rev, 19: 192-201.
112. Somjen, D., Weisman, Y., Kohen, F., et al. 2005. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation, 111: 1666-71.
113. Song, Y. H., Naumova, A. K., Liebhaber, S. A., & Cooke, N. E. 1999. Physical and meiotic mapping of the region of human chromosome 4q11-q13 encompassing the vitamin D binding protein DBP/Gc-globulin and albumin multigene cluster. Genome Res, 9: 581-7.
114. Speeckaert, M. M., Taes, Y. E., De Buyzere, M. L., et al. 2010. Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem, 47: 143-50.
115. Speeckaert, M. M., Wehlou, C., Vandewalle, S., et al. 2008. Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients. Clin Chem Lab Med, 46: 365-70.
116. Speliotes, E. K., Willer, C. J., Berndt, S. I., et al. 2010. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet, 42: 937-48.
117. Sun, Q., Shi, L., Rimm, E. B., et al. 2011. Vitamin D intake and risk of cardiovascular disease in U.S. men and women. Am J Clin Nutr, 94: 534-42.
118. Suzuki, Y., Ichiyama, T., Ohsaki, A., et al. 2009. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol, 113: 134-8.
119. Taes, Y. E., Goemaere, S., Huang, G., et al. 2006. Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone, 38: 701-7.
120. Takeda, M., Yamashita, T., Sasaki, N., et al. 2010. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol, 30: 2495-503.
121. Teslovich, T. M., Musunuru, K., Smith, A. V., et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466: 707-13.
122. Thadhani, R., Appelbaum, E., Pritchett, Y., et al. 2012. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: The PRIMO randomized controlled trial. JAMA, 307: 674-84.
123. 3 supplementation in raising serum 25(OH)D status: A systematic review and meta-analysis. Am J Clin Nutr, 95(6): 1357-64.
124. Unal, B., Critchley, J. A., & Capewell, S. 2004. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation, 109: 1101-7.
125. Wang, T. J., Zhang, F., Richards, J. B., et al. 2010. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet, 376: 180-8.
126. Wang, Y., & Deluca, H. F. 2011. Is the vitamin D receptor found in muscle? Endocrinology, 152: 354-63.
127. Webb, A. R., Decosta, B. R., & Holick, M. F. 1989. Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab, 68: 882-7.
128. Winters, S. J., Chennubhatla, R., Wang, C., & Miller, J. J. 2009. Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism, 58: 438-42.
129. Witke, W. F., Gibbs, P. E., Zielinski, R., et al. 1993. Complete structure of the human Gc gene: Differences and similarities between members of the albumin gene family. Genomics, 16: 751-4.
130. Wjst, M., Altmuller, J., Faus-Kessler, T., et al. 2006. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Respir Res, 7: 60.
131. Wolden-Kirk, H., Overbergh, L., Christesen, H. T., Brusgaard, K., & Mathieu, C. 2011. Vitamin D and diabetes: Its importance for beta cell and immune function. Mol Cell Endocrinol, 347: 106-20.
132. Wood, A. M., Bassford, C., Webster, D., et al. 2011. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax, 66: 205-10.
133. Wu-Wong, J. R., Nakane, M., Ma, J., Ruan, X., & Kroeger, P. E. 2007. VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells. J Cell Biochem, 100: 1395-405.
134. Yamamoto, N., & Homma, S. 1991. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc Natl Acad Sci U S A, 88: 8539-43.
135. Ye, W. Z., Dubois-Laforgue, D., Bellanne-Chantelot, C., Timsit, J., & Velho, G. 2001. Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians. Metabolism, 50: 366-9.
136. Young, K. A., Snell-Bergeon, J. K., Naik, R. G., et al. 2011. Vitamin D deficiency and coronary artery calcification in subjects with type 1 diabetes. Diabetes Care, 34: 454-8.
137. Zella, L. A., Shevde, N. K., Hollis, B. W., Cooke, N. E., & Pike, J. W. 2008. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology, 149: 3656-67.
138. Zhou, C., Lu, F., Cao, K., et al. 2008. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int, 74: 170-9.